IMMUNIC, INC. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
New York, United States
SEC filing record 1 source field available
Fiscal year end
31 December
IMMUNIC, INC. has filed 830 SEC EDGAR filings since 18 Feb 2004

SEC filing history

Showing 601-625 of 821 matching filings.

Per page
25
Current page
25
4

FORM 4

Filing date
25 May 2017
Reporting date
23 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
25 May 2017
Reporting date
23 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
25 May 2017
Reporting date
23 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36201

8-K

Filing date
25 May 2017
Reporting date
23 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36201

8-K

Filing date
09 May 2017
Reporting date
09 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-36201

DEFA14A

Filing date
11 Apr 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-36201

DEF 14A

Filing date
11 Apr 2017
Reporting date
11 Apr 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-88651

SC 13D

Filing date
04 Apr 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36201

8-K

Filing date
29 Mar 2017
Reporting date
29 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
27 Mar 2017
Reporting date
27 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36201

8-K

Filing date
23 Mar 2017
Reporting date
22 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-204097

424B5

Filing date
23 Mar 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-204097

424B5

Filing date
21 Mar 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36201

8-K

Filing date
21 Mar 2017
Reporting date
21 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36201

8-K

Filing date
07 Mar 2017
Reporting date
07 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-88651

SC 13G/A filing

Filing date
14 Feb 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-88651

SC 13G/A

Filing date
13 Feb 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-88651

AMENDMENT NO. 2 TO FORM SC 13G

Filing date
13 Feb 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-88651

VITAL THERAPIES 13G-A 123116

Filing date
10 Feb 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
5

FORM 5

Filing date
17 Jan 2017
Reporting date
31 Dec 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36201

8-K

Filing date
03 Nov 2016
Reporting date
03 Nov 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-88651

VITAL THERAPIES INC 13G 073116

Filing date
23 Sep 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .